MORE►
UT Southwestern Medical Center
Left to right: Muhammad Rizwan, Ph.D., Assistant Professor of Biomedical Engineering and Ophthalmology at UT Southwestern; Madhukar Patel, M.D., M.B.A., Sc.M., Assistant Professor of Surgery and Surgical Director of the Liver Transplantation Program; and Samuel Achilefu, Ph.D., inaugural Chair of Biomedical Engineering and Professor in the Harold C. Simmons Comprehensive Cancer Center and of Radiology at UT Southwestern [Photos: UTSW]
UT Southwestern Secures Up to $25M ARPA‑H Award to Bioengineer Artificial Livers
by Maddie Preston | Jan 13, 2026
The project, known as Vascularized Immunocompetent Tissue as an Alternative Liver, or VITAL, aims to "biofabricate" functioning livers using patients' own cells and advanced 3D printing techniques.
by Quincy Preston |
Oct 15, 2025
Researchers at UTSW identified a set of neurons in the "brain's timekeeper" that may drive nighttime snacking—and in mice, control up to 7% of body weight. The discovery could pave the way for new weight-loss strategies.
MORE►
by Lance Murray |
Sep 18, 2025
UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program that moves discoveries into clinical trials.
MORE►
by Lance Murray |
Sep 11, 2025
The discovery reveals why people may be more susceptible to infections at certain times of day—and could open new paths for cancer immunotherapy and infection treatments.
MORE►
[Illustration: Sittipol Sukuna/istockphoto]
UT Dallas, UT Southwestern Among Six 2025 iC3 Tech Transfer Showcase Finalists
by David Seeley | Aug 19, 2025
Part of the 2025 iC³ Life Science & Healthcare Innovation Summit to be held September 16-17 in Dallas, the showcase pitch event is designed to connect university researchers with potential investors, industry executives, and strategic partners. This is the first year the showcase has expanded beyond Texas.
MORE►
by Lance Murray |
Aug 18, 2025
The Dallas-based firm will provide program management and oversee construction activity for the new medical campus from Children’s Health and UT Southwestern.
MORE►
by Maddie Preston |
Aug 8, 2025
The funding supports UT Arlington researcher Junzhou Huang, whose team recently ranked first in protein contact prediction and placed sixth overall in an international AI challenge competing against Google DeepMind, the University of Washington, and others.
MORE►
by Lance Murray |
Jul 24, 2025
Using a new tool developed at UT Southwestern Medical Center, researchers identified a gene that seems to be key in regulating food intake, offering a different pathway for potential obesity treatments.
MORE►
Signify Bio co-founders, from left: CEO R.A. Session II and Chief Scientific Officer Daniel Siegwart, Ph.D., of UT Southwestern. {Photos: Taysha Gene Therapies/UTSW]
Dallas’ Signify Bio Launches With Oversubscribed $15M Financing, Partnership With UT Southwestern
by Lance Murray | Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
by Lance Murray |
May 25, 2025
The Dallas-based medical center is one of just two in Texas offering osseointegration, a revolutionary implant technique that gives amputees better control, comfort—and for 50-year-old Scott Bryson, the chance to walk his daughter down the aisle.
MORE►
by Lance Murray |
May 6, 2025
To recognize the foundation's "record-breaking" support, the hospital at the new Dallas pediatric campus will be named Moody Children's Hospital upon completion in 2031.
MORE►
by Lance Murray |
May 2, 2025
A UT Southwestern study of blind fruit flies and mice reveals a brain-wide stress response, shedding light on the biological link between sensory loss and dementia.
MORE►
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
by Quincy Preston |
Feb 20, 2025
The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, vaccines, and breakthrough biologics from lab bench to patients. Funded in part by Lyda Hill Philanthropies, the National Center for Therapeutics Manufacturing Satellite Campus is set to open this summer.
MORE►
by Lance Murray |
Feb 14, 2025
A clinical trial led by researchers at UT Southwestern Medical Center in Dallas could help bring an experimental treatment for depression closer to approval from the U.S....
MORE►
by Lance Murray |
Feb 5, 2025
Dr. Kirk Calhoun was named interim president following the resignation in January of UNTHSC President Sylvia Trent-Adams.
MORE►
